Jobs / United States / Natera INC
Clinical Oncology Specialist, GU
Natera INC · 🇺🇸 Boston, MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 12 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Natera INC paid sponsored hires in similar roles1 certified filing for “Clinical Lab Scientist I” (Medical and Clinical Laboratory Technologists) in CA: $86k–$86k, median $86k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Natera INC
The US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 12 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Natera INC →
About the role
Territory: New England Natera is seeking an experienced Clinical Oncology Specialist (COS) to join our specialized Genitourinary (GU) Oncology sales team. This high-impact, tumor-specific role will focus on driving adoption and growth of Signatera™, Natera's personalized, tumor-informed molecular residual disease (MRD) test , across the GU Oncology landscape. Signatera is a circulating tumor DNA (ctDNA) assay designed to detect molecular residual disease and monitor disease recurrence. Across GU cancers, including bladder, renal cell carcinoma, and testicular cancers, Signatera provides highly specific molecular insights that can help clinicians assess recurrence risk, monitor disease status, and inform individualized patient management strategies. The Clinical Oncology Specialist will serve as a strategic field partner and key representative of Natera Oncology, developing relationships with Key Opinion Leaders (KOLs) and healthcare providers across academic medical centers, integrated delivery networks, hospital systems, and select community oncology practices. This position will have a primary focus on Urologic Oncology, with key call points including Urologic Oncologists, GU Surgical Oncologists, Radiation Oncologists, Medical Oncologists, Pathologists, and other healthcare providers involved in the diagnosis, treatment, and ongoing management of patients with genitourinary cancers. Primary Responsibilities • Develop and execute strategic territory business plans to drive Signatera adoption, achieve sales objectives, and maximize market opportunities. • Build and strengthen relationships with Urologic Oncologists, GU Surgical Oncologists, Medical Oncologists, Radiation Oncologists, Pathologists, and other key stakeholders across the GU Oncology continuum of care. • Drive new account acquisition, expand existing partnerships, and identify growth opportunities within academic medical centers, hospital systems, leading urology practices, and community oncology networks. • Educate healthcare providers on Signatera's clinical applications, supporting evidence, and value in the management of GU cancers, including bladder, kidney, and testicular cancers. • Develop relationships with Key Opinion Leaders (KOLs) specializing in GU Oncology, particularly within major academic medical centers and leading urology and oncology practices. • Establish expertise in Natera's molecular diagnostics technology, clinical evidence, product offerings, and competitive landscape. • Collaborate closely with Natera's Core Oncology Sales team and cross-functional partners to align account strategies and maximize commercial effectiveness. • Identify opportunities to expand Signatera adoption through physician education, strategic account development, and multidisciplinary care team engagement. • Navigate complex healthcare systems, reimbursement processes, and institutional requirements to support successful product adoption. • Partner with internal teams to resolve operational challenges, support account needs, and ensure a positive customer experience. • Collaborate with Medical Affairs to support appropriate scientific engagement and KOL development in accordance with company policies. • Support the development of institutional care pathways, account-level workflows, and EMR integrations to facilitate testing adoption. • Monitor market trends, competitive dynamics, and evolving clinical evidence in GU Oncology to identify opportunities for territory growth. • Execute sales and marketing initiatives aligned with regional and national Oncology objectives. Qualifications • Bachelor's degree required. • Minimum of 5 years of demonstrated sales success within Oncology, Urology, Urologic Oncology, Medical Devices, Molecular Diagnostics, C